Mol Autism. 2013 Apr 09;4(1):7. doi: 10.1186/2040-2392-4-7.
Prevalence of autism in mainland China, Hong Kong and Taiwan: a systematic review and meta-analysis.
Molecular autism
Xiang Sun, Carrie Allison, Fiona E Matthews, Stephen J Sharp, Bonnie Auyeung, Simon Baron-Cohen, Carol Brayne
Affiliations
Affiliations
- Department of Public Health and Primary Care, Institute of Public Health, University of Cambridge, Forvie Site, Robinson Way, Cambridge, CB2 0SR, UK. [email protected].
PMID: 23570419
PMCID: PMC3643868 DOI: 10.1186/2040-2392-4-7
Abstract
BACKGROUND: The prevalence of autism spectrum conditions (ASC) is 1% in developed countries, but little data are available from mainland China, Hong Kong and Taiwan. This study synthesizes evidence relating to the prevalence of ASC in these areas and assesses the effects of research methodology on prevalence estimates.
METHODS: Systematic literature searches were conducted in PubMed, Web of Knowledge, China Web of Knowledge and Weipu databases, as well as relevant papers published from 1987 to 2011, reporting prevalence estimates of ASC or childhood autism in mainland China, Hong Kong and Taiwan. Summary estimates of prevalence were calculated with a random effects model. The effects of research methodology on the prevalence estimates were assessed using a meta-regression model.
RESULTS: There were 25 studies eligible for review, 18 of which were suitable for inclusion in a meta-analysis. Pooled prevalence of childhood autism was 11.8 per 10,000 individuals (95% confidence interval (CI): 8.2, 15.3) in mainland China. Pooled prevalence of ASC was 26.6 per 10,000 (95% CI: 18.5, 34.6) in three areas. Substantial heterogeneity was identified between studies (I2>75%). The prevalence estimate of childhood autism was most strongly associated with the choice of screening instrument. After adjustment for age group, the odds ratio for prevalence estimates when using the Autism Behavior Checklist (ABC) as the screening instrument compared with those using the Clancy Autism Behavior Scale (CABS) was 0.29 (95% CI: 0.12, 0.69), and 1.79 (95% CI: 0.70, 4.55; P= 0.20) when using the Checklist for Autism in Toddlers (CHAT) compared to the CABS.
CONCLUSIONS: The available studies investigating the prevalence of ASC in China, Hong Kong and Taiwan have focused mainly on childhood autism rather than the whole spectrum. The prevalence estimates are lower than estimates from developed countries. Studies using more recently developed screening instruments reported higher prevalence than older ones. However, available studies have methodological weaknesses and therefore these results lack comparability with those from developed countries. Our findings indicate a potential under-diagnosis and under-detection of ASC in mainland China, Hong Kong and Taiwan, and a need to adopt more advanced methods for research of ASC in these areas.
References
- Neuropsychol Rev. 2008 Dec;18(4):287-304 - PubMed
- Pro Fono. 2008 Apr-Jun;20(2):111-6 - PubMed
- Pediatr Res. 2009 Jun;65(6):591-8 - PubMed
- MMWR Surveill Summ. 2012 Mar 30;61(3):1-19 - PubMed
- Autism. 2009 May;13(3):317-36 - PubMed
- Br J Psychiatry. 2009 Jun;194(6):500-9 - PubMed
- J Child Neurol. 2008 Jan;23(1):67-72 - PubMed
- Epilepsy Behav. 2011 Dec;22(4):786-9 - PubMed
- Public Health Rep. 2004 Nov-Dec;119(6):536-51 - PubMed
- Psychiatry Clin Neurosci. 2008 Apr;62(2):152-9 - PubMed
- J Autism Dev Disord. 1994 Oct;24(5):659-85 - PubMed
- Br J Psychiatry. 1992 Dec;161:839-43 - PubMed
- J Autism Dev Disord. 2005 Oct;35(5):625-34 - PubMed
- Acta Paediatr. 2005 Jan;94(1):2-15 - PubMed
- J Child Psychol Psychiatry. 2004 Feb;45(2):212-29 - PubMed
- Acta Paediatr. 2008 May;97(5):539-40 - PubMed
- Autism Res Treat. 2012;2012:910946 - PubMed
- J Autism Dev Disord. 1980 Mar;10(1):91-103 - PubMed
- Gen Hosp Psychiatry. 2003 Jul-Aug;25(4):284-8 - PubMed
- Acta Psychiatr Scand. 2001 Jun;103(6):428-34 - PubMed
- Arch Pediatr Adolesc Med. 2007 Apr;161(4):415-6 - PubMed
- J Autism Dev Disord. 2009 Jun;39(6):897-909 - PubMed
- J Child Psychol Psychiatry. 1980 Jul;21(3):221-9 - PubMed
- J Autism Dev Disord. 1989 Jun;19(2):185-212 - PubMed
- Child Care Health Dev. 1994 May-Jun;20(3):165-77 - PubMed
- J Child Neurol. 2011 Jul;26(7):830-4 - PubMed
- Res Dev Disabil. 2013 Jan;34(1):294-305 - PubMed
- Biomed Environ Sci. 2005 Oct;18(5):334-40 - PubMed
- Am J Psychiatry. 2011 Sep;168(9):904-12 - PubMed
- Soc Sci Med. 2010 Jun;70(12):2045-2051 - PubMed
- J Autism Dev Disord. 1987 Jun;17(2):289-96 - PubMed
- Lancet. 2002 Mar 9;359(9309):881-4 - PubMed
- Arch Dis Child. 2007 Jun;92(6):540-5 - PubMed
- J Autism Dev Disord. 1988 Mar;18(1):81-97 - PubMed
- Res Dev Disabil. 2013 Jan;34(1):469-79 - PubMed
- Soc Psychiatry Psychiatr Epidemiol. 2010 Mar;45(3):319-27 - PubMed
- Pediatrics. 2006 Apr;117(4):1436-7 - PubMed
- Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Jun;22(3):254-7 - PubMed
- J Autism Dev Disord. 2002 Feb;32(1):13-23 - PubMed
- Res Dev Disabil. 2013 Jan;34(1):440-51 - PubMed
- Pediatrics. 2011 Jun;127(6):1043-51 - PubMed
- Br J Psychiatry. 1996 Aug;169(2):228-35 - PubMed
- Arch Dis Child. 2006 Jan;91(1):8-15 - PubMed
- Dev Med Child Neurol. 1969 Aug;11(4):432-42 - PubMed
- BMJ. 2003 Sep 6;327(7414):557-60 - PubMed
Publication Types
Grant support